With extensive expertise in early-stage investments, the fund manager has successfully executed over 50 deals across technology and healthcare sectors. Their strategic approach emphasizes a data-driven methodology, focusing particularly on innovative startups in Europe and North America. Notable exits include several high-growth companies that reflect a strong operator-first strategy. This experience positions them to identify transformative opportunities within rapidly evolving markets.